PCVX
Vaxcyte·NASDAQ
--
--(--)
--
--(--)
3.85 / 10
Netural
Capital flow assessment yields 7.69/10, denoting robust fund flow characteristics. Strengths in Small, Medium, and Large trends confront pressures from overall, block, and Extra-large patterns, resulting in positive liquidity outlook. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(100.0%) from 1 analyst assessments, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-02
InstitutionGuggenheim
Times predicted3
Historical Win Rate0.0%
What is the market sentiment for PCVX?
- PCVX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.85/10 (Netural).
